Chapter 1.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– By Product
6.1. Vitamin and Mineral Supplements
6.1.1. Vitamin C Supplements
6.1.2. Vitamin D Supplements
6.1.3. Vitamin B complex Supplements
6.1.4. Multivitamins
6.1.5. Selenium Supplements
6.1.6. Zinc Supplements
6.1.7. Others
6.2. Herbal Supplements
6.3. Probiotic Supplements
6.4. Others
Chapter 7.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– By Form
7.1. Capsules
7.2. Tablets
7.3. Powder
7.4. Liquid
7.5. Gel
7.6. Soft gels
7.7. Others
Chapter 8. GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– By Distribution Channel
8.1. Pharmacies/Drug Stores
8.2. Supermarkets and Hypermarkets
8.3. E-commerce
8.4. Others
Chapter 9. GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– By Region
9.1. North America
9.2. Europe
9.3. The Asia Pacific
9.4. Latin America
9.5. The Middle East
9.6. Africa
Chapter 10.GLOBAL GERIATRIC IMMUNE HEALTH SUPPLEMENT MARKET– Key Players
10.1.Bayer AG
10.2. Pfizer Inc.
10.3. Sun Pharmaceutical Industries Limited
10.4. Swisse Wellness Pty Ltd.
10.5. GlaxoSmithKline Inc.
10.6. Abbott Laboratories
10.7. Amway Corp.
10.8. The Nature's Bounty Co.
10.9. Herbalife Nutrition of America, Inc.
10.10. Himalaya Global Holdings Ltd.
10.11. American Health
10.12. Unilever
10.13. Sanofi
10.14. Novartis
10.15. Boehringer Ingelheim
2850
5250
4500
1800